Smac mimetics (University of California Los Angeles)

N/A

Report date: 2025/02/05 14:37:22
NME

Base Information

Drug NameSmac mimetics (University of California Los Angeles)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDiablo homolog, mitochondrial modulators
TargetsDiablo homolog, mitochondrial
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Virus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaUniversity Of California, Los Angeles
Active IndicationsN/A
Inactive IndicationsObesityDiabetes Mellitus, Type 2Virus Diseases

Other Information

ATC CodeN/A
Related LinksN/A